Back to Search Start Over

Biogen Idec says it's rebounding strongly

Source :
Boston Globe (Boston, MA). March 13, 2006
Publication Year :
2006

Abstract

Byline: Jeffrey Krasner Mar. 13--The suspension of the multiple sclerosis drug Tysabri on Feb. 28, 2005, was the start of a difficult year for Biogen Idec Inc. of Cambridge. When [...]

Details

Language :
English
ISSN :
07431791
Database :
Gale General OneFile
Journal :
Boston Globe (Boston, MA)
Publication Type :
News
Accession number :
edsgcl.143175667